Episode

What to expect this flu season

Podcast
Health Report
Published
Apr 3, 2026
Duration seconds
2522
Processing state
not_requested
Canonical source
https://www.abc.net.au/listen/programs/healthreport/flu-season-2026/106458256
Audio
https://mediacore-live-production.akamaized.net/audio/02/j7/Z/l1.mp3
JSON
/v1/public/podcasts/health-report-318292/episodes/what-to-expect-this-flu-season
Markdown
/podcast/health-report-318292/what-to-expect-this-flu-season.md

Actions

  • POST https://stenobird.com/v1/public/podcasts/health-report-318292/episodes/what-to-expect-this-flu-season/transcription-requests
    Idempotently request low-priority transcript generation for this episode.
  • GET https://stenobird.com/podcast/health-report-318292/what-to-expect-this-flu-season.md
    Read the agent-friendly Markdown representation of this episode resource.

Summary

Which flu strains are likely to be dominant this flu season - and what's the story with the new nasal spray vaccine? Speaking of sprays ... there's a simple saline spray that might help kids with sleep apnoea avoid surgery. And a treatment for enlarged prostate that doesn't involve going under the knife. Plus, a new review finds vaping is likely to cause certain types of cancer. References: The carcinogenicity of e-cigarettes: a qualitative risk assessment Cost-Effectiveness of Oral Immunotherapy Treatments vs No Treatment for Peanut Allergy in Children Annual Immunisation Coverage Report 2025 Vaping likely to cause cancer, new Australian review of evidence finds (ABC News) Influenza (flu) vaccine - Department of Health Influenza immunisation resources - National Centre for Immunisation Research and Surveillance Historic 1994 influenza vaccine cohorts define breadth of antibody and B cell responses toward future influenza A and B viruses Lab Notes: Super-K flu is here … but it's not our biggest problem Intranasal Treatments for Children With Sleep-Disordered Breathing: The MIST+ Randomized Clinical Trial Prostate artery Embolisation Assessment of Safety and feasibilitY (P-EASY): a potential alternative to long-term medical therapy for benign prostate hyperplasia The ‘Prostate Embolisation AS first-line therapY compAred to meDication in treatment naïVe men with prostAte eNlargement, a randomised ControllEd trial’ (P-EASY ADVANCE): a randomised controlled trial of prostate embolisation vs medication for BPH Prostate artery EmbolisAtion Safety and efficacY: Preliminary and foLlow-Up urodynamic Studies (P-EASY PLUS)